Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CISPLATIN Cause Diffuse large b-cell lymphoma? 320 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 320 reports of Diffuse large b-cell lymphoma have been filed in association with CISPLATIN (CISplatin). This represents 0.7% of all adverse event reports for CISPLATIN.

320
Reports of Diffuse large b-cell lymphoma with CISPLATIN
0.7%
of all CISPLATIN reports
59
Deaths
40
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From CISPLATIN?

Of the 320 reports, 59 (18.4%) resulted in death, 40 (12.5%) required hospitalization, and 25 (7.8%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CISPLATIN. However, 320 reports have been filed with the FAERS database.

What Other Side Effects Does CISPLATIN Cause?

Off label use (4,359) Disease progression (3,746) Neutropenia (3,095) Febrile neutropenia (3,010) Nausea (2,923) Drug ineffective (2,608) Thrombocytopenia (2,565) Anaemia (2,530) Vomiting (2,326) Diarrhoea (2,022)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which CISPLATIN Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

CISPLATIN vs CISPLATIN\CYTARABINE\DEXAMETHASONE CISPLATIN vs CITALOPRAM CISPLATIN vs CITALOPRAM HYDROBROMIDE CISPLATIN vs CITALOPRAM\CITALOPRAM HYDROBROMIDE CISPLATIN vs CITICOLINE

Related Pages

CISPLATIN Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma CISPLATIN Demographics